Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-4718
Zeilhofer, H U; Calò, G (2003). Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy? Journal of Pharmacology and Experimental Therapeutics, 306(2):423-429.
- Registered users only
View at publisher
The neuropeptide nociceptin, also called orphanin FQ (N/OFQ), is the endogenous agonist of the N/OFQ peptide receptor (NOP receptor). Both N/OFQ and the NOP receptor share a high degree of homology with classical opioid peptides and opioid receptors, respectively, and use similar signal transduction pathways as classical opioids. The NOP receptor has thus been regarded as the fourth member of the opioid receptor family. Despite this close relationship, 7 years of research have demonstrated that the N/OFQ system has a distinct pharmacological profile and serves different physiological functions. In particular, its role in the control of pain and analgesia at different levels of integration appears quite different from that of classical opioids. The recent development of specific antagonists at the NOP receptor and of NOP receptor or N/OFQ precursor knock-out mice have generated new insights into the role of N/OFQ in pain processing and help to evaluate the N/OFQ-NOP system as a potential target for new analgesic drugs.
1 download since deposited on 26 Mar 2009
0 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Institute of Pharmacology and Toxicology|
|Dewey Decimal Classification:||570 Life sciences; biology
610 Medicine & health
|Deposited On:||26 Mar 2009 11:00|
|Last Modified:||02 Dec 2013 07:41|
|Publisher:||American Society for Pharmacology and Experimental Therapeutics|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page